Galactose metabolism and ovarian toxicity

Reproductive Toxicology

Volumn 14, Issue 5, 2000, Pages 377-384

  Liu, Gentao ^a   Hale, Georgina E ^a   Hughes, Claude L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Galactose; Metabolism; Ovary; Pathogenesis of galactose; Prevention of galactose toxicity

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; ANTIOXIDANT; DIETHYLSTILBESTROL; GALACTITOL; GALACTOSE; GALACTOSE 1 PHOSPHATE; GONADOTROPIN; PROGESTERONE; TESTOSTERONE PROPIONATE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GALACTOSE;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CANCER RISK; CARBOHYDRATE METABOLISM; FEMALE; FOOD COMPOSITION; FOOD INTAKE; GALACTOSEMIA; HUMAN; NONHUMAN; OVARY CARCINOMA; OVARY DISEASE; RAT; REPRODUCTIVE TOXICITY; REVIEW;

ANIMALS; FEMALE; GALACTOSE; GALACTOSEMIAS; HUMANS; OVARIAN DISEASES;

ANIMALIA; FALLOPIA; MAMMALIA;

EID: 0033745157     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(00)00096-4     Document Type: Review

References (89)

1. Galactose disorder: An overview
2. Galactose metabolism in human ovarian tissue
3. Ovarian failure in galactosemia
4. Lactase persistence and milk consumption as determinants of ovarian cancer risk
5. Galactose-1-phosphate uridyltransferase activity associated with age at menopause and reproductive history
6. Fruits and vegetables are a source of galactose: Implications in planning the diets of patients with galactosemia
7. Hidden sources of galactose in the environment
8. Lifetime milk consumption and bone mineral density in older women
9. Consumption of calcium in the US: Food sources and intake levels
10. Galactose consumption, metabolism, and follicle-stimulating hormone concentrations in women of late reproductive age
11. Quantitative assessment of whole body galactose metabolism in galactosemia patients
12. Digestion and absorption: Water soluble organics
13. The absorption of monosaccharides in man
14. The influence of glucose on serum galactose levels in man
15. Effects of trecadrine, a beta 3-adrenergic agonist, on intestinal absorption of D-galactose and disaccharidase activities in three physiopathological models
16. Presence of leptin receptors in rat small intestine and leptin effect on sugar absorption
17. Changing activities of galactose metabolizing enzymes during perfusing of suckling rat liver
18. Gonadal function in galactosemics and in galactose-intoxicated animals
19. Ovarian androgen secretion in patients with galactosemia and premature ovarian failure
20. Gonadal function and ovarian galactose metabolism in classic galactosemia
21. Ovarian failure in galactosemia
22. Hypergonadotropic hypogonadism in female patients with galactosemia
23. Gonadal function in patients with galactosemia
24. Correlation of ovarian function with galactose-1-phosphate uridyl transferase levels in galactosemia
25. Long-term prognosis in galactosemia: Results of a survey of 350 cases
26. Long-term outcome in 134 patients with galactosemia
27. Gonadal failure in young women and galactose-1-phosphate uridyl transferase activity
28. Galactosemia
29. Hormonal status of galactosemia homozygotes
30. Ovarian failure in galactosemia
31. Resistant ovary syndrome and premature ovarian failure in young woman with galactosemia
32. Regional activity of galactose-1-phosphate uridyltransferase in rat brain
33. Developmental and tissue-specific modulation of rat galactose-1-phosphate uridyltransferase steady state messenger RNA and specific activity levels
34. Reduction in oocyte number following prenatal exposure to a diet high in galactose
35. Galactose inhibition of ovulation in mice
36. Aldose reductase inhibition prevention prevents galactose-induced ovarian dysfunction in the Sprague-Dawley rat
37. OECD guidelines for testing of chemicals A new guideline for avian reproduction toxicity test in the Japanese quail or Northern Bobwhite
38. Ovarian toxicity of galactose and its preventive effects by taurine in egg-laying Japanese Quail
39. The role of galactose-1-phosphate in the pathogenesis of galactosemia
40. Galactose metabolism, hereditary defects and their clinical significance
41. Inhibitor studies on uridine diphosphoglucose pyrophosphorylase
42. Galactose biogenesis and disposal in galactosemia
43. The metabolism of lactose and galactose
44. Red blood cell uridine sugar nucleotide levels in patients with classic galactosemia and other metabolic disorders
45. Uridine diphosphoglucose content of human erythrocytes: Assessments by conversion to uridine diphosphoglucuronate
46. Galactosemia: The uridine diphosphate galactose deficiency-uridine treatment controversy
47. Deficit of uridine diphosphate galactose in galactosemia
48. Disorders of galactose metabolism
49. Galactose metabolism in male and female rats. I. Blood and urinary differences
50. Resistance of the male gonad to a high galactose diet
51. Expression of galactose-1-phosphate uridyltransferase in the anterior pituitary of rat during the estrus cycle
52. Altered follicle stimulating hormone isoforms in female galactosemia patients
53. The ovarian follicular apparatus
54. Apoptosis in steroidogenic cells: Structure-function analysis
55. Regulation of ovarian follicle atresia
56. Evaluation of aldose reductase inhibitor vs sorbitol, dehydrogenase inhibitor on diabetes-induced changes in retinal NAD(P)-redox status support for the role for aldose reductase but not sorbitol dehydrogenase in diabetic retinopathy
57. Galactose induces apoptosis of dog retinal capillary pericytes, but not of endothelial cells
58. Premature ovarian failure: An update
59. Premature ovarian failure and ovarian autoimmunity
60. Gonadal cell apoptosis
61. Septicemia in galactosemia
62. 2 in human umbilical vein endothelial cells cultured in high glucose medium
63. Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agents
64. Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats
65. Nerve function and regeneration in diabetic and galactosemic rats: Antioxidant and metal chelator effects
66. Associations between nutrition and cataract
67. Taurine prevents galactose-induced cataracts
68. A physiological level of ascorbate inhibits galactose cataract in guinea pigs by decreasing polyol accumulation in the lens epithelium: A dehydroascorbate-linked mechanism
69. Activation of aldose reductase by nonenzymatic glycosylation
70. The role of polyols in the pathophysiology of hypergalactosemia
71. Effects of seven days of galactose feeding and aldose reductase inhibition on mast cells and vessel morphometry in rat sciatic nerve
72. Schwann cell changes induced as early as one week after galactose intoxication
73. Effects of aldose reductase inhibitor CT-112 on the corneal epithelial barrier of galactose-fed rats
74. Regulation of galactose metabolism: Implications for therapy
75. Progesterone effects on galactose metabolism in prepubertal patients with congenital galactosemia and in rats maintained on high galactose diets
76. A consideration of galactose toxicity in male and female chicks
77. Adult hypolactasia, milk consumption and age-specific fertility
78. Galactose consumption and metabolism in relation to the risk of ovarian cancer
79. Lactose absorption in patients with ovarian cancer
80. Mutation of galactose-1-phosphate uridyl transferase and its association with ovarian cancer and endometriosis
81. Dietary lactose intake, lactose intolerance, and the risk of epithelial ovarian cancer in southern Ontario (Canada)
82. A case-control study of milk drinking and ovarian cancer risk
83. Milk consumption, galactose metabolism and ovarian cancer (Australia)
84. Lactose and galactose intake and metabolism in relation to the risk of epithelial ovarian cancer
85. The reliabiity of dietary history from the distant past
86. Dietary animal fat in relation to ovarian cancer risk
87. Characteristics of women with a family history of ovarian cancer. I. Galactose consumption and metabolism
88. Galactose consumption and risk of ovarian cancer